TBI scheme impacted on relapse in acute myeloid leukemia patients after hematopoietic stem cell transplant

被引：0
|
作者：
Palazzari, E. [1 ]
Amico, L. [2 ]
Santucci, A. [3 ]
Carotti, A. [2 ]
Perrucci, E. [4 ]
Cavalli, A. [4 ]
Velardi, A. [2 ]
Aristei, C. [5 ,6 ]
机构：
[1] Univ Perugia, Dept Radiat Oncol, Perugia, Italy
[2] Univ Perugia, Div Hematol & Clin Immunol, Dept Med, Perugia, Italy
[3] Univ Perugia, Hematol & Clin Immunol Sect, Perugia, Italy
[4] Santa Maria Misericordia Hosp, Dept Radiat Oncol, Perugia, Italy
[5] Univ Perugia, Dept Radiat Oncol, Perugia, Italy
[6] Santa Maria Misericordia Hosp, Dept Radiat Oncol, Perugia, Italy
来源：
RADIOTHERAPY AND ONCOLOGY | 2015年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-1352
引用
收藏
页码：S729 / S729
页数：1
相关论文
共 50 条
  • [31] Comparison of Different Conditioning Regimens of Haploidentical Hematopoietic Stem Cell Transplant in Patients With Acute Myeloid Leukemia
    Jiang, Yujie
    Fang, Xiaosheng
    Sui, Xiaohui
    Liu, Xin
    Li, Ying
    Wang, Xianghua
    Xu, Hongzhi
    Zhang, Lingyan
    Wang, Xin
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2018, 16 (06) : 736 - 744
  • [32] OUTCOME OF ACUTE MYELOID LEUKEMIA RELAPSE AFTER ALLOGENIC STEM CELL TRANSPLANT: A SINGLE INSTITUTION RETROSPECTIVE STUDY
    Castoldi, YC.
    Hicheri, Y.
    Devillier, R.
    Hospital, MA.
    D'Incan, E.
    Garciaz, S.
    Maisano, V.
    Saillard, C.
    Rey, J.
    Granata, A.
    Harbi, S.
    Legrand, F.
    Furst, S.
    Blaise, D.
    Vey, N.
    ANNALS OF HEMATOLOGY, 2023, 102 (SUPPL 1) : S56 - S56
  • [33] Cytogenetic evolution predicts a poor prognosis in acute myeloid leukemia patients who relapse after allogeneic hematopoietic stem cell transplantation
    Li, Ruiqi
    Wang, Ziwei
    Zhang, Yuesheng
    Guo, Mengqiao
    Ni, Xiong
    Chen, Jie
    Chen, Li
    Gao, Lei
    Gong, Shenglan
    Tang, Gusheng
    Yang, Jianmin
    Wang, Jianmin
    ANNALS OF HEMATOLOGY, 2023, 102 (01) : 89 - 97
  • [34] Cytogenetic evolution predicts a poor prognosis in acute myeloid leukemia patients who relapse after allogeneic hematopoietic stem cell transplantation
    Ruiqi Li
    Ziwei Wang
    Yuesheng Zhang
    Mengqiao Guo
    Xiong Ni
    Jie Chen
    Li Chen
    Lei Gao
    Shenglan Gong
    Gusheng Tang
    Jianmin Yang
    Jianmin Wang
    Annals of Hematology, 2023, 102 : 89 - 97
  • [35] Relapse after allogeneic hematopoietic stem cell transplant in patients with chronic myeloid leukemia: tyrosine kinase inhibitors, donor lymphocyte infusions or both?
    Eskazan, Ahmet Emre
    Erdogan, Isil
    Berk, Selin
    Yalniz, Fevzi Firat
    Elverdi, Tugrul
    Salihoglu, Ayse
    Soysal, Teoman
    LEUKEMIA & LYMPHOMA, 2015, 56 (10) : 2995 - 2996
  • [36] Hypomethylating Agents for Relapse After Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia
    Im, Annie
    Raptis, Anastasios
    Hou, Jing-Zhou
    Tompkins, Cheryl
    Loucks, Melissa
    Guay, Mary
    Phillips, Julie
    Boyiadzis, Michael
    Agha, Mounzer
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S293 - S293
  • [37] Strategies to Reduce Relapse after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia
    Mawad, Raya
    Lionberger, Jack M.
    Pagel, John M.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2013, 8 (02) : 132 - 140
  • [38] Intensive chemotherapy for acute myeloid leukemia relapse after allogeneic hematopoietic cell transplantation
    Krakow, Elizabeth F.
    Walter, Roland B.
    Nathe, Julia M.
    Perez, Tess
    Ahmed, Ali
    Polissar, Nayak
    Miljacic, Ljubomir
    Halpern, Anna B.
    Flowers, Mary E. D.
    Estey, Eli
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (06) : E220 - E223
  • [39] Hematopoietic cell transplantation soon after first relapse in acute myeloid leukemia - the CONS
    Ofran, Yishai
    Rowe, Jacob M.
    HAEMATOLOGICA, 2025, 110 (01) : 7 - 10
  • [40] Strategies to Reduce Relapse after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia
    Raya Mawad
    Jack M. Lionberger
    John M. Pagel
    Current Hematologic Malignancy Reports, 2013, 8 : 132 - 140
12345